Over 1 in 5 hospitalized patients develop AKI. Optimizing medication dosing is a key focus area for clinical pharmacy, as teams are dealing with increasingly complex patients. Yet, pharmacists are routinely challenged by dosing and monitoring of vancomycin, requiring clinicians to take many considerations into account including patient demographic data and laboratory results to individualize dosing for each patient.
Studies have shown that using Bayesian dosing to calculate a precise dose results in significant improvements in mortality, medication safety, patient outcomes, and cost savings. As more pharmacy teams move toward Bayesian dosing, they look to leverage tools to support them and automate workflow, ensuring every patient receives an optimal dose to improve outcomes.
In this webinar, we will:
- Review AUC dosing workflows and the benefits of a Bayesian dosing tool integrated directly into Sentri7® Clinical Surveillance for vancomycin – say goodbye to data entry!
- Discuss how pharmacy teams are adopting Bayesian dosing tools to streamline workflows, allow automated access to faster, more precise calculations, and proactively monitor therapy to reduce a patient’s risk of acute kidney injury (AKI).
- Discover best practices for standardizing care with a data-driven approach to dose optimization and keeping prescribing in line with your hospital’s antimicrobial stewardship goals and the CDC’s Core Elements.
- Demonstrate live the reimagined interface of DoseMeRx and Sentri7 integration designed with hospitals pharmacists to be (even more) intuitive – exploring new features including single page design, note and comments sections for easy transition at handovers, edit data function plus much more.
